The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-03
DOI
10.3389/fneur.2020.00045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Motor neuron loss in SMA is not associated with somal stress-activated JNK/c-Jun signaling
- (2019) Celeste M Pilato et al. HUMAN MOLECULAR GENETICS
- Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
- (2019) Marc‐Olivier Deguise et al. Annals of Clinical and Translational Neurology
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
- (2019) Darryl C. De Vivo et al. NEUROMUSCULAR DISORDERS
- Chromatolysis: Do injured axons regenerate poorly when ribonucleases attack rough endoplasmic reticulum, ribosomes and RNA?
- (2018) Lawrence David Falcon Moon Developmental Neurobiology
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice
- (2018) Roberta Schellino et al. Frontiers in Molecular Neuroscience
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal Administrations
- (2017) Kenneth T. Luu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- ERK and ROCK functionally interact in a signaling network that is compensationally upregulated in Spinal Muscular Atrophy
- (2017) Niko Hensel et al. NEUROBIOLOGY OF DISEASE
- Spinal muscular atrophy: A changing phenotype beyond the clinical trials
- (2017) Eduardo F. Tizzano et al. NEUROMUSCULAR DISORDERS
- The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?
- (2017) Niko Hensel et al. NEUROSCIENTIST
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Converging Mechanisms of p53 Activation Drive Motor Neuron Degeneration in Spinal Muscular Atrophy
- (2017) Christian M. Simon et al. Cell Reports
- Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III
- (2017) Heike Kölbel et al. PLoS One
- Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
- (2016) Eilidh Somers et al. ANNALS OF NEUROLOGY
- Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
- (2016) L. A. Nash et al. CURRENT MOLECULAR MEDICINE
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Genetic inhibition of JNK3 ameliorates spinal muscular atrophy
- (2015) Naresh K. Genabai et al. HUMAN MOLECULAR GENETICS
- Astrocytes influence the severity of spinal muscular atrophy
- (2015) Hansjörg Rindt et al. HUMAN MOLECULAR GENETICS
- Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I
- (2015) Brian N. Harding et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline
- (2015) Sarah Gourmaud et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- PTEN Depletion Decreases Disease Severity and Modestly Prolongs Survival in a Mouse Model of Spinal Muscular Atrophy
- (2015) Daniel Little et al. MOLECULAR THERAPY
- Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders
- (2015) Neelroop N. Parikshak et al. NATURE REVIEWS GENETICS
- 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands
- (2015) Richard Finkel et al. NEUROMUSCULAR DISORDERS
- FunRich: An open access standalone functional enrichment and interaction network analysis tool
- (2015) Mohashin Pathan et al. PROTEOMICS
- Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders
- (2015) Niko Hensel et al. Frontiers in Neuroscience
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
- (2014) A Sclip et al. Cell Death & Disease
- Bilateral crosstalk of rho- and extracellular-signal-regulated-kinase (ERK) pathways is confined to an unidirectional mode in spinal muscular atrophy (SMA)
- (2013) Niko Hensel et al. CELLULAR SIGNALLING
- Shift from Extracellular Signal-Regulated Kinase to AKT/cAMP Response Element-Binding Protein Pathway Increases Survival-Motor-Neuron Expression in Spinal-Muscular-Atrophy-Like Mice and Patient Cells
- (2013) J. Branchu et al. JOURNAL OF NEUROSCIENCE
- Glucose metabolism and pancreatic defects in spinal muscular atrophy
- (2012) Melissa Bowerman et al. ANNALS OF NEUROLOGY
- Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
- (2012) Melissa Bowerman et al. BMC Medicine
- Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy
- (2012) T. L. Martinez et al. JOURNAL OF NEUROSCIENCE
- Synaptic defects in type I spinal muscular atrophy in human development
- (2012) Rebeca Martínez-Hernández et al. JOURNAL OF PATHOLOGY
- Prospective cohort study of spinal muscular atrophy types 2 and 3
- (2012) P. Kaufmann et al. NEUROLOGY
- Analysis of the Fibroblast Growth Factor System Reveals Alterations in a Mouse Model of Spinal Muscular Atrophy
- (2012) Niko Hensel et al. PLoS One
- The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
- (2011) J. N. Sleigh et al. Disease Models & Mechanisms
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens
- (2011) Elaine A Sugarman et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The spinal muscular atrophy disease protein SMN is linked to the rho-kinase pathway via profilin
- (2011) Anna Nölle et al. HUMAN MOLECULAR GENETICS
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Early Functional Impairment of Sensory-Motor Connectivity in a Mouse Model of Spinal Muscular Atrophy
- (2011) George Z. Mentis et al. NEURON
- Spinal muscular atrophy
- (2011) Adele D'Amico et al. Orphanet Journal of Rare Diseases
- Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
- (2010) Mélissa Bowerman et al. HUMAN MOLECULAR GENETICS
- Digital necroses and vascular thrombosis in severe spinal muscular atrophy
- (2010) Sabine Rudnik-Schöneborn et al. MUSCLE & NERVE
- The BioGRID Interaction Database: 2011 update
- (2010) C. Stark et al. NUCLEIC ACIDS RESEARCH
- Spinal Muscular Atrophy: Newborn and Carrier Screening
- (2010) Thomas W. Prior OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon
- (2009) Andrea Tedeschi et al. EMBO REPORTS
- Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy
- (2009) Alexandra prufer de Queiroz Campos Araujo et al. JOURNAL OF PEDIATRICS
- SMN, profilin IIa and plastin 3: A link between the deregulation of actin dynamics and SMA pathogenesis
- (2009) Mélissa Bowerman et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
- (2009) Arthur H. M. Burghes et al. NATURE REVIEWS NEUROSCIENCE
- The IntAct molecular interaction database in 2010
- (2009) B. Aranda et al. NUCLEIC ACIDS RESEARCH
- Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation
- (2009) E. R. Hollis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect
- (2008) T. O. Gavrilina et al. HUMAN MOLECULAR GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started